Laura Bessen - 29 Jul 2022 Form 3 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role: Director
Signature: /s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol: CCCC
Transactions as of: 29 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 02 Aug 2022, 16:18:36 UTC
Next filing: 16 Jun 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney